Medicom Conference Report ASN 2022最新文献

筛选
英文 中文
Lowering blood pressure intervention favourable for CV outcomes 降低血压干预有利于心血管预后
Medicom Conference Report ASN 2022 Pub Date : 2022-12-08 DOI: 10.55788/1ca4759c
C. de Koning
{"title":"Lowering blood pressure intervention favourable for CV outcomes","authors":"C. de Koning","doi":"10.55788/1ca4759c","DOIUrl":"https://doi.org/10.55788/1ca4759c","url":null,"abstract":"","PeriodicalId":261282,"journal":{"name":"Medicom Conference Report ASN 2022","volume":"63 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121630700","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Significantly higher risk of overcorrection in hyponatraemic patients with standard bolus infusion 低钠血症患者采用标准单次输注出现矫治过度的风险显著增高
Medicom Conference Report ASN 2022 Pub Date : 2022-12-08 DOI: 10.55788/42c747dd
C. de Koning
{"title":"Significantly higher risk of overcorrection in hyponatraemic patients with standard bolus infusion","authors":"C. de Koning","doi":"10.55788/42c747dd","DOIUrl":"https://doi.org/10.55788/42c747dd","url":null,"abstract":"","PeriodicalId":261282,"journal":{"name":"Medicom Conference Report ASN 2022","volume":"17 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132042023","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Balanced crystalloid solution better for deceased donor kidney transplantations 平衡晶体溶液更适合已故供体肾脏移植
Medicom Conference Report ASN 2022 Pub Date : 2022-12-08 DOI: 10.55788/31c0844a
C. de Koning
{"title":"Balanced crystalloid solution better for deceased donor kidney transplantations","authors":"C. de Koning","doi":"10.55788/31c0844a","DOIUrl":"https://doi.org/10.55788/31c0844a","url":null,"abstract":"","PeriodicalId":261282,"journal":{"name":"Medicom Conference Report ASN 2022","volume":"8 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115726178","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Combining UACR and GFR improves prediction of drug effect in CKD phase 2 trials 联合UACR和GFR改善了CKD 2期临床试验中药物疗效的预测
Medicom Conference Report ASN 2022 Pub Date : 2022-12-08 DOI: 10.55788/57ba55db
C. de Koning
{"title":"Combining UACR and GFR improves prediction of drug effect in CKD phase 2 trials","authors":"C. de Koning","doi":"10.55788/57ba55db","DOIUrl":"https://doi.org/10.55788/57ba55db","url":null,"abstract":"","PeriodicalId":261282,"journal":{"name":"Medicom Conference Report ASN 2022","volume":"5 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126550076","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cooler dialysate does not offer any clinical benefits 较冷的透析液不提供任何临床益处
Medicom Conference Report ASN 2022 Pub Date : 2022-12-08 DOI: 10.55788/360649fe
C. de Koning
{"title":"Cooler dialysate does not offer any clinical benefits","authors":"C. de Koning","doi":"10.55788/360649fe","DOIUrl":"https://doi.org/10.55788/360649fe","url":null,"abstract":"","PeriodicalId":261282,"journal":{"name":"Medicom Conference Report ASN 2022","volume":"47 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123129244","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-term nephroprotective effects of sparsentan in FSGS 斯帕替坦对FSGS的长期肾保护作用
Medicom Conference Report ASN 2022 Pub Date : 2022-12-08 DOI: 10.55788/c16e9006
C. de Koning
{"title":"Long-term nephroprotective effects of sparsentan in FSGS","authors":"C. de Koning","doi":"10.55788/c16e9006","DOIUrl":"https://doi.org/10.55788/c16e9006","url":null,"abstract":"","PeriodicalId":261282,"journal":{"name":"Medicom Conference Report ASN 2022","volume":"23 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121757766","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cemdisiran shows promise in IgA nephropathy Cemdisiran在IgA肾病中显示出希望
Medicom Conference Report ASN 2022 Pub Date : 2022-12-08 DOI: 10.55788/dfd5357e
C. de Koning
{"title":"Cemdisiran shows promise in IgA nephropathy","authors":"C. de Koning","doi":"10.55788/dfd5357e","DOIUrl":"https://doi.org/10.55788/dfd5357e","url":null,"abstract":"","PeriodicalId":261282,"journal":{"name":"Medicom Conference Report ASN 2022","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133020700","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antiviral effect of MAU868 against BK virus prompts further research MAU868对BK病毒的抗病毒作用有待进一步研究
Medicom Conference Report ASN 2022 Pub Date : 2022-12-08 DOI: 10.55788/73972a7e
C. de Koning
{"title":"Antiviral effect of MAU868 against BK virus prompts further research","authors":"C. de Koning","doi":"10.55788/73972a7e","DOIUrl":"https://doi.org/10.55788/73972a7e","url":null,"abstract":"","PeriodicalId":261282,"journal":{"name":"Medicom Conference Report ASN 2022","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128525000","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Novel MSC therapy appears safe and effective in preventing decline in eGFR 新型骨髓间充质干细胞治疗在预防eGFR下降方面安全有效
Medicom Conference Report ASN 2022 Pub Date : 2022-12-08 DOI: 10.55788/f3f48173
C. de Koning
{"title":"Novel MSC therapy appears safe and effective in preventing decline in eGFR","authors":"C. de Koning","doi":"10.55788/f3f48173","DOIUrl":"https://doi.org/10.55788/f3f48173","url":null,"abstract":"","PeriodicalId":261282,"journal":{"name":"Medicom Conference Report ASN 2022","volume":"24 2 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128642255","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Isuzinaxib effective in patients with CKD and T2D isuzinaxb对CKD和T2D患者有效
Medicom Conference Report ASN 2022 Pub Date : 2022-12-08 DOI: 10.55788/442b6b48
C. de Koning
{"title":"Isuzinaxib effective in patients with CKD and T2D","authors":"C. de Koning","doi":"10.55788/442b6b48","DOIUrl":"https://doi.org/10.55788/442b6b48","url":null,"abstract":"","PeriodicalId":261282,"journal":{"name":"Medicom Conference Report ASN 2022","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130885507","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信